Astellas announced that China NMPA approved XTANDI for the treatment of prostate cancer
The FINANCIAL -- Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D., "Astellas") today announced that the China National ...
ADVERTISEMENT
Tag: prostate cancer
Cancer-detection company GRAIL files to go public
The FINANCIAL -- GRAIL, a healthcare company yesterday, on September 9 announced that it has filed a registration statement on Form ...
ADVERTISEMENT
Popular Last 24h
-
Ampersand wins £22m five-year contract at London Zoo
-
The London Diplomatic List, Addresses, Contacts & Working Hours
-
Magical Night: Unique Hotels in Scandinavia
-
Biden Job Approval Second Lowest Among Post-WWII Presidents
-
Georgia advanced to 8th position in world economic freedom ranking
-
Who Is the Owner of QI Company? A Look at the QI Group’s Leadership Shaping Its Future
-
Patricia White Appointed as a Class C Director to the New York Fed Board of Directors
LATEST POSTS
LATESTINTERVIEWS
ADVERTISEMENT
